User Fee Exemption From Sequester Could Take Flight
This article was originally published in The Pink Sheet Daily
A bipartisan group of House appropriations committee members indicate concern about the potential FDA problems that could arise if user fee revenue remains part of the mandatory budget cuts.
You may also be interested in...
User fees, not appropriations, will make up the bulk of FDA’s human drug spending if President Obama’s FY 2014 budget comes to pass, a trend fueled by new user fee programs and cuts to taxpayer funding.
Twenty sponsors now have applications in the new review model, but none have reached the approval decision stage; industry officials say it still is too early to draw conclusions.
The estimated reduction, included in the White House Office of Management and Budget’s report to Congress, is equal the cost of 900 to 1,200 agency employees, an agency advocate said.